Nea Management Company, LLC Ardelyx, Inc. Transaction History

Nea Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $11.7 Million - $23.2 Million	-13,633,582 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$5.37 - $8.11 $13.4 Million - $20.3 Million	-2,501,465 Reduced 15.5%	13,633,582 $94.3 Million
Q4 2019 Jan 24, 2020	BUY	$4.23 - $8.29 $3.38 Million - $6.63 Million	800,000 Added 5.22%	16,135,047 $121 Million
Q2 2018 Aug 09, 2018	BUY	$3.7 - $5.8 $4.63 Million - $7.26 Million	1,251,465 Added 8.89%	15,335,047 $56.7 Million
Q3 2017 Nov 03, 2017	BUY	$4.35 - $5.7 $61.3 Million - $80.3 Million	14,083,582	14,083,582 $78.9 Million

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.